Position in LLY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$36,477,068
+$8,389,229 QoQ
Shares Held
30,412
+16.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.19%
of 13F equity value
Holder Rank
#637
of 4,605 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026J.W. COLE ADVISORS, INC. holds $121,333,460 across 13 Drug Manufacturers - General names. LLY ranks #1 (30.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
30,412 | $36,477,068 | |
| 2 | JNJ |
Johnson & Johnson
|
113,666 | $28,867,754 | |
| 3 | ABBV |
AbbVie Inc.
|
73,916 | $18,600,222 | |
| 4 | MRK |
Merck & Co., Inc.
|
100,135 | $12,867,347 | |
| 5 | AMGN |
Amgen Inc
|
16,509 | $5,978,239 | |
| 6 | PFE |
Pfizer Inc
|
235,737 | $5,676,546 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
30,495 | $3,852,738 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
59,835 | $3,447,692 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,477,068 | 30,412 | Shares | Sole | 2026-07-21 | |
| 2025-12-31 | $28,087,839 | 26,136 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $19,757,885 | 25,895 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $19,573,218 | 25,109 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $15,533,715 | 18,808 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $7,602,656 | 9,848 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $8,458,955 | 9,548 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $8,458,965 | 9,343 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $7,146,340 | 9,186 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $5,278,923 | 9,056 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $5,084,472 | 9,466 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $4,668,226 | 9,954 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $4,202,430 | 12,237 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $2,727,703 | 7,456 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,460,046 | 7,608 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $2,193,740 | 6,766 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $1,804,417 | 6,301 | Shares | Sole | 2022-06-10 | |
| 2021-12-31 | $1,485,787 | 5,379 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $1,177,661 | 5,097 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $1,075,530 | 4,686 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $807,436 | 4,322 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $553,119 | 3,276 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,761,734 | 11,902 | Shares | Sole | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||